DOI QR코드

DOI QR Code

Advances in Intravascular Imaging: New Insights into the Vulnerable Plaque from Imaging Studies

  • Yonetsu, Taishi (Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital) ;
  • Jang, Ik-Kyung (Cardiology Division, Massachusetts General Hospital, Harvard Medical School)
  • Received : 2017.08.14
  • Accepted : 2017.10.09
  • Published : 2018.01.31

Abstract

The term "vulnerable plaque" denotes the plaque characteristics that are susceptible to coronary thrombosis. Previous post-mortem studies proposed 3 major mechanisms of coronary thrombosis: plaque rupture, plaque erosion, and calcified nodules. Of those, characteristics of rupture-prone plaque have been extensively studied. Pathology studies have identified the features of rupture-prone plaque including thin fibrous cap, large necrotic core, expansive vessel remodeling, inflammation, and neovascularization. Intravascular imaging modalities have emerged as adjunctive tools of angiography to identify vulnerable plaques. Multiple devices have been introduced to catheterization laboratories to date, including intravascular ultrasound (IVUS), virtual-histology IVUS, optical coherence tomography (OCT), coronary angioscopy, and near-infrared spectroscopy. With the use of these modalities, our understanding of vulnerable plaque has rapidly grown over the past several decades. One of the goals of intravascular imaging is to better predict and prevent future coronary events, for which prospective observational data is still lacking. OCT delineates microstructures of plaques, whereas IVUS visualizes macroscopic vascular structures. Specifically, plaque erosion, which has been underestimated in clinical practice, is gaining an interest due to the potential of OCT to make an in vivo diagnosis. Another potential future avenue for intravascular imaging is its use to guide treatment. Feasibility of tailored therapy for acute coronary syndromes (ACS) guided by OCT is under investigation. If it is proven to be effective, it may potentially lead to major shift in the management of millions of patients with ACS every year.

Keywords

References

  1. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-34. https://doi.org/10.1136/hrt.50.2.127
  2. Friedman M, Van den Bovenkamp GJ. Role of thrombus in plaque formation in the human diseased coronary artery. Br J Exp Pathol 1966;47:550-7.
  3. Willerson JT, Campbell WB, Winniford MD, et al. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. Am J Cardiol 1984;54:1349-54. https://doi.org/10.1016/S0002-9149(84)80095-8
  4. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990;82:II38-46.
  5. Davies MJ, Thomas AC. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-73. https://doi.org/10.1136/hrt.53.4.363
  6. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481-8. https://doi.org/10.1161/CIRCULATIONAHA.105.537878
  7. Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 1994;23:809-13. https://doi.org/10.1016/0735-1097(94)90772-2
  8. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75. https://doi.org/10.1161/01.ATV.20.5.1262
  9. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664-72. https://doi.org/10.1161/01.CIR.0000087480.94275.97
  10. Arbustini E, Dal Bello B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999;82:269-72. https://doi.org/10.1136/hrt.82.3.269
  11. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003;108:1772-8. https://doi.org/10.1161/01.CIR.0000087481.55887.C9
  12. Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004;110:2032-8. https://doi.org/10.1161/01.CIR.0000143233.87854.23
  13. Kolodgie FD, Burke AP, Farb A, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001;16:285-92. https://doi.org/10.1097/00001573-200109000-00006
  14. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13-8. https://doi.org/10.1016/j.jacc.2005.10.065
  15. Kato K, Yonetsu T, Kim SJ, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 2012;5:433-40. https://doi.org/10.1161/CIRCIMAGING.112.973701
  16. García-García HM, Mintz GS, Lerman A, et al. Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention 2009;5:177-89. https://doi.org/10.4244/EIJV5I2A29
  17. Sathyanarayana S, Carlier S, Li W, Thomas L. Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroIntervention 2009;5:133-9. https://doi.org/10.4244/EIJV5I1A21
  18. Okubo M, Kawasaki M, Ishihara Y, et al. Tissue characterization of coronary plaques: comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasound. Circ J 2008;72:1631-9. https://doi.org/10.1253/circj.CJ-07-0936
  19. Garcìa-Garcìa HM, Gogas BD, Serruys PW, Bruining N. IVUS-based imaging modalities for tissue characterization: similarities and differences. Int J Cardiovasc Imaging 2011;27:215-24. https://doi.org/10.1007/s10554-010-9789-7
  20. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-9. https://doi.org/10.1016/S0735-1097(01)01799-5
  21. Prati F, Guagliumi G, Mintz GS, et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 2012;33:2513-20. https://doi.org/10.1093/eurheartj/ehs095
  22. Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;59:1058-72. https://doi.org/10.1016/j.jacc.2011.09.079
  23. Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-5. https://doi.org/10.1161/01.CIR.0000029927.92825.F6
  24. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-5. https://doi.org/10.1161/01.CIR.0000159354.43778.69
  25. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006;97:1172-5. https://doi.org/10.1016/j.amjcard.2005.11.035
  26. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006;97:1713-7. https://doi.org/10.1016/j.amjcard.2006.01.031
  27. Mizuno K, Satomura K, Miyamoto A, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992;326:287-91. https://doi.org/10.1056/NEJM199201303260502
  28. Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991;337:809-12. https://doi.org/10.1016/0140-6736(91)92514-3
  29. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-82. https://doi.org/10.1056/NEJM199705013361802
  30. Kume T, Akasaka T, Kawamoto T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006;152:755.e1-4. https://doi.org/10.1016/j.ahj.2006.06.030
  31. Yonetsu T, Kakuta T, Lee T, et al. In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J 2011;32:1251-9. https://doi.org/10.1093/eurheartj/ehq518
  32. Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-40. https://doi.org/10.1161/01.CIR.103.7.934
  33. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-8. https://doi.org/10.1161/01.CIR.0000025609.13806.31
  34. Tian J, Ren X, Vergallo R, et al. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol 2014;63:2209-16. https://doi.org/10.1016/j.jacc.2014.01.061
  35. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-35. https://doi.org/10.1056/NEJMoa1002358
  36. Maehara A, Cristea E, Mintz GS, et al. Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. JACC Cardiovasc Imaging 2012;5:S1-9. https://doi.org/10.1016/j.jcmg.2011.11.019
  37. Brown AJ, Obaid DR, Costopoulos C, et al. Direct comparison of virtual-histology intravascular ultrasound and optical coherence tomography imaging for identification of thin-cap fibroatheroma. Circ Cardiovasc Imaging 2015;8:e003487.
  38. Uemura S, Ishigami K, Soeda T, et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 2012;33:78-85. https://doi.org/10.1093/eurheartj/ehr284
  39. Takano M, Jang IK, Inami S, et al. In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics. Am J Cardiol 2008;101:471-6. https://doi.org/10.1016/j.amjcard.2007.09.106
  40. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:1478-92. https://doi.org/10.1016/S0735-1097(01)01175-5
  41. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-65. https://doi.org/10.1001/jama.295.13.jpc60002
  42. Takayama T, Hiro T, Yamagishi M, et al. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009;73:2110-7. https://doi.org/10.1253/circj.CJ-09-0358
  43. Nicholls SJ, Puri R, Anderson T, et al. Effect of evolocumab on progression of coronary disease in statintreated patients: the GLAGOV Randomized Clinical Trial. JAMA 2016;316:2373-84. https://doi.org/10.1001/jama.2016.16951
  44. Xing L, Higuma T, Wang Z, et al. Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study. J Am Coll Cardiol 2017;69:2502-13.
  45. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-81. https://doi.org/10.1136/hrt.69.5.377
  46. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44. https://doi.org/10.1161/01.CIR.89.1.36
  47. Nathan CF, Murray HW, Cohn ZA. The macrophage as an effector cell. N Engl J Med 1980;303:622-6. https://doi.org/10.1056/NEJM198009113031106
  48. Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003;107:113-9. https://doi.org/10.1161/01.CIR.0000044384.41037.43
  49. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-9. https://doi.org/10.1016/j.jacc.2004.05.066
  50. Vergallo R, Papafaklis MI, Yonetsu T, et al. Endothelial shear stress and coronary plaque characteristics in humans: combined frequency-domain optical coherence tomography and computational fluid dynamics study. Circ Cardiovasc Imaging 2014;7:905-11. https://doi.org/10.1161/CIRCIMAGING.114.001932
  51. Phipps JE, Hoyt T, Vela D, et al. Diagnosis of thin-capped fibroatheromas in intravascular optical coherence tomography images: effects of light scattering. Circ Cardiovasc Interv 2016;9:e003163. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003163
  52. Kini AS, Vengrenyuk Y, Yoshimura T, et al. Fibrous cap thickness by optical coherence tomography in vivo. J Am Coll Cardiol 2017;69:644-57.
  53. Kume T, Okura H, Yamada R, et al. Detection of plaque neovascularization by optical coherence tomography: ex vivo feasibility study and in vivo observation in patients with angina pectoris. J Invasive Cardiol 2016;28:17-22.
  54. Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995;26:450-6. https://doi.org/10.1016/0046-8177(95)90148-5
  55. Gössl M, Versari D, Hildebrandt HA, et al. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. JACC Cardiovasc Imaging 2010;3:32-40.
  56. Kitabata H, Tanaka A, Kubo T, et al. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease. Am J Cardiol 2010;105:1673-8. https://doi.org/10.1016/j.amjcard.2010.01.346
  57. Taruya A, Tanaka A, Nishiguchi T, et al. Vasa vasorum restructuring in human atherosclerotic plaque vulnerability: a clinical optical coherence tomography study. J Am Coll Cardiol 2015;65:2469-77. https://doi.org/10.1016/j.jacc.2015.04.020
  58. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-9. https://doi.org/10.1016/j.jacc.2007.04.082
  59. Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 2013;62:1748-58. https://doi.org/10.1016/j.jacc.2013.05.071
  60. Higuma T, Soeda T, Abe N, et al. A combined optical coherence tomography and intravascular ultrasound study on plaque rupture, plaque erosion, and calcified nodule in patients with ST-segment elevation myocardial infarction: incidence, morphologic characteristics, and outcomes after percutaneous coronary intervention. JACC Cardiovasc Interv 2015;8:1166-76. https://doi.org/10.1016/j.jcin.2015.02.026
  61. Hu S, Yonetsu T, Jia H, et al. Residual thrombus pattern in patients with ST-segment elevation myocardial infarction caused by plaque erosion versus plaque rupture after successful fibrinolysis: an optical coherence tomography study. J Am Coll Cardiol 2014;63:1336-8. https://doi.org/10.1016/j.jacc.2013.11.025
  62. Jia H, Dai J, Hou J, et al. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). Eur Heart J 2017;38:792-800.
  63. Lee JB, Mintz GS, Lisauskas JB, et al. Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodules. Am J Cardiol 2011;108:1547-51. https://doi.org/10.1016/j.amjcard.2011.07.014
  64. Xu Y, Mintz GS, Tam A, et al. Prevalence, distribution, predictors, and outcomes of patients with calcified nodules in native coronary arteries: a 3-vessel intravascular ultrasound analysis from Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT). Circulation 2012;126:537-45. https://doi.org/10.1161/CIRCULATIONAHA.111.055004
  65. Lee T, Mintz GS, Matsumura M, et al. Prevalence, predictors, and clinical presentation of a calcified nodule as assessed by optical coherence tomography. JACC Cardiovasc Imaging 2017;10:883-91. https://doi.org/10.1016/j.jcmg.2017.05.013
  66. Qian D, Bottomley PA. High-resolution intravascular magnetic resonance quantification of atherosclerotic plaque at 3T. J Cardiovasc Magn Reson 2012;14:20. https://doi.org/10.1186/1532-429X-14-20
  67. Jaffer FA, Calfon MA, Rosenthal A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol 2011;57:2516-26. https://doi.org/10.1016/j.jacc.2011.02.036
  68. Li BH, Leung AS, Soong A, et al. Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis. Catheter Cardiovasc Interv 2013;81:494-507. https://doi.org/10.1002/ccd.24295

Cited by

  1. Vulnerable Plaque, Characteristics, Detection, and Potential Therapies vol.6, pp.3, 2019, https://doi.org/10.3390/jcdd6030026
  2. Predictors of acute coronary syndrome in patients with ischaemic heart disease vol.26, pp.3, 2018, https://doi.org/10.33529/angi02020302
  3. Intravascular imaging of atherosclerotic plaques in patients with cardiorenal syndrome: potential use of optical coherence tomography vol.21, pp.4, 2018, https://doi.org/10.15825/1995-1191-2019-4-121-128
  4. Predictors of Coronary Plaque Vulnerability in Patients with Stable Coronary Artery Disease vol.60, pp.10, 2020, https://doi.org/10.18087/cardio.2020.10.n1188
  5. Using Optical Coherence Tomography and Intravascular Ultrasound Imaging to Quantify Coronary Plaque Cap Stress/Strain and Progression: A Follow-Up Study Using 3D Thin-Layer Models vol.9, pp.None, 2018, https://doi.org/10.3389/fbioe.2021.713525
  6. Optical Coherence Tomography based treatment approach for patients with Acute Coronary Syndrome vol.19, pp.2, 2018, https://doi.org/10.1080/14779072.2021.1857732